Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Who is Fidji Simo? OpenAI's top executive for AGI deployment steps down due to health concerns as AI race intensifies
Fidji Simo, a senior OpenAI executive, has stepped down after taking medical leave due to a chronic neuroimmune condition. She will continue as a part-time adviser while her responsibilities are divided among three executives.
Central Drugs Laboratories find 46 drug samples not of standard quality for May
Health officials revealed that in May 2026, 46 drug samples tested by Central Drugs Laboratories and 113 by State Drugs Testing Laboratories were found to be of substandard quality. Additionally, one spurious drug, manufactured by an unauthorized entity using another company's brand, was identified in Assam and is under investigation. These findings highlight ongoing efforts to ensure drug safety and remove substandard products from circulation.
Alembic Pharmaceuticals receives USFDA approval for Tretinoin Cream USP, 0.05%
Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Tretinoin Cream USP, 0.05%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Retin-A Cream, 0.05%, of Bausch Health US, LLC. Tretinoin cream is indicated for topical application in the treatment of acne vulgaris.
Stock Alert: SBI, Aurionpro Solutions, MedPlus Health, Honasa Consumer, Bharat Wire Ropes, IOL Chemicals & Pharma - Business Standard
Stock Alert: SBI, Aurionpro Solutions, MedPlus Health, Honasa Consumer, Bharat Wire Ropes, IOL Chemicals & PharmaBusiness Standard
Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concerns
The Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approval for semaglutide injections. A diabetes patient raised concerns about the drug's delivery system, alleging it deviates from global standards and poses health risks. The court has directed the CDSCO to consider the patient's representation within two months.
Alembic gets USFDA nod for generic levothyroxine sodium tablets
Alembic Pharmaceuticals has secured final approval from the US health regulator for its generic levothyroxine sodium tablets. This medication is used as a replacement therapy for hypothyroidism. The approval covers multiple strengths of the tablets. This development is significant for patients seeking affordable treatment options. The market for these tablets is substantial.
India faces no immediate public health threat from hantavirus: NIV chief
Two Indian nationals aboard a cruise ship have reportedly contracted hantavirus. Indian health officials assure the public that these cases appear isolated. There is no immediate public health threat to India. Experts confirm hantavirus does not spread easily among people. India possesses adequate laboratory capacity for diagnosis. Standard rodent control and sanitation remain key preventive measures.
Enduring wealth, lasting wellness. People in India are living longer. Are they also living well?
India's rising life expectancy faces a longevity paradox, with increased years not always translating to good health, compounded by rising medical inflation and low insurance penetration. Standard Chartered is bridging this gap by integrating health and wealth management through partnerships with Niva Bupa and WHOOP, focusing on proactive wellness and curated experiences for affluent clients.
OpenAI COO Shifts Out of Role, AGI CEO Taking Medical Leave
OpenAI’s chief operating officer is shifting into a new role and two other top executives are going on leave due to health reasons, marking a major change to its executive bench ahead of a potential Wall Street debut as soon as this year.
Fractal Analytics, Park Medi, two others slip up to 7% as lock-in for 3.6 crore shares expires today
Following the end of IPO lock-in periods on March 16, Fractal Analytics, Aye Finance, Park Medi World, and Nephrocare Health Services faced share price drops. This release of 3.6 crore shares marks the beginning of a potential $72 billion unlock for 88 companies through 2026.
Shriram General Insurance launches 'Shri Health Suraksha 2.0'
In response to evolving healthcare needs, Shriram General Insurance Company announced the launch of Shri Health Suraksha 2.0, an enhanced health insurance suite engineered for greater flexibility and 'all-inclusive' protection. This indemnity plan addresses critical gaps in traditional coverage by removing standard caps on room charges and adding unlimited restoration benefits.
Stock market today: From Swiggy, IRFC to RVNL— More than 700 stocks hit 52-week lows on BSE amid stock market crash
As many as 719 stocks, including Swiggy, SBI Cards and Payment Services, IRFC, RVNL, REC, Concor, DLF, Naukri, Page Industries, Procter & Gamble Hygiene and Health Care, and Shree Cement, hit their 52-week lows in intraday trade on the BSE.